Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients With Atrial Fibrillation
New Orleans, Louisiana, November 11 (ots/PRNewswire) - - New Post-Hoc Analysis From Athena Study Showed That Multaq(R) on Top of Standard Therapy Significantly Decreased the Total Number of Hospital Days by 28% in Patients With Atrial Fibrillation or Flutter NEW ORLEANS, Louisiana, November 11 /PRNewswire/ ...